Longevity Families of the Netherlands

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age75+
SponsorLeiden University Medical Center

About this trial

The demographic life expectancy enhancement of the past 150 years imposes an urgent challenge in Western and economically growing societies to stimulate the healthy lifespan that is lagging behind. Families surviving into exceptionally high ages (longevity) in good physical and mental health illustrate that this is physiologically possible. Such families harbor cross generational socio-genetic mechanisms that mediate healthy aging and protection from (multi)morbidity.

The purpose of our research is: to identify gene variants associated with healthy aging and protection from (multi)morbidity; to study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component.

Eligibility criteria

Qualifiers

Siblings of Dutch Caucasian descent age 75+ enriched for familial longevity

Individuals of Dutch Caucasian descent age 75+ who are not enriched for familial longevity

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

600 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Leiden University Medical Center

Lead sponsor

Jacobijn Gussekloo, Prof. dr.

Collaborator

Simon P. Mooijaart, Prof. dr.

Collaborator